Werewolf Therapeutics, Inc.

NASDAQ:HOWL

Biotechnology

Healthcare
$1.03 +6.12%

+$0.06 today

Market cap
$50.06M
Beta
0.29
P/E (TTM)
-1.4
EPS (TTM)
-$0.71
52W Low $0.27High $1.83

Volume 1.85M

Average 5.09M

Balance Sheet

Inspect the capital base behind the business.

Assets

$69.40M

FY 2025 · Annual

-45.3% YoY

Liabilities

$44.59M

FY 2025 · Annual

-16.7% YoY

Equity

$24.80M

FY 2025 · Annual

-66.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents157.53M129.32M134.34M111M57.95M
Short-term Investments00000
Net Receivables06.93M1.35M00
Inventory00000
Other Current Assets100K3.96M2.68M2.07M635K
Total Current Assets161.07M140.2M138.37M113.07M58.59M
Property, Plant & Equipment (Net)16.33M17.45M14.85M12.32M9.9M
Goodwill00000
Intangible Assets00000
Long-term Investments01.21M21.02M1.22M901K
Tax Assets00000
Other Non-current Assets1.86M1.38M594K320K5K
Total Non-current Assets18.18M20.05M36.46M13.86M10.81M
Total Assets179.25M160.25M174.83M126.93M69.4M
Account Payables2.04M1.22M1.34M3.04M754K
Short-term Debt006.67M01.75M
Tax Payables00000
Deferred Revenue06.53M907K00
Other Current Liabilities163K11.02M3.63M3.62M33.64M
Total Current Liabilities11.87M23.99M19.38M15.18M36.15M
Long-term Debt0032.66M26.1M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities01.32M433K2.83M759K
Total Non-current Liabilities14.59M13.92M44.08M38.36M8.44M
Total Liabilities26.46M37.91M63.46M53.54M44.59M
Common Stock2K3K4K5K5K
Retained Earnings(252.9M)(306.71M)(344.07M)(414.59M)(475.41M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity152.79M122.34M111.37M73.39M24.81M
Total Debt15.66M14.68M51.92M37.09M9.44M
Net Debt(141.87M)(114.63M)(82.42M)(73.91M)(48.52M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$22.0M
Other Current$905.0K
Total Current Assets$22.9M
PP&E (Net)$1.3M
Total Non-current Assets$1.3M
Total Assets$24.2M

Analysis

Selected assets total $24.2M for Latest. The largest visible component is Cash & Equivalents at $22.0M, about 91.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 16, 2026
10-QQuarterly reportNov 13, 2026
EFFECTEFFECT filingNov 12, 2026
424B3424B3 filingNov 12, 2026
S-4/AS-4/A filingNov 10, 2026

How much cash does HOWL have?

Werewolf Therapeutics, Inc. (HOWL) reported $57.95M in cash and equivalents in fiscal 2025.

How much debt does HOWL carry?

Werewolf Therapeutics, Inc. (HOWL) reported $9.44M of total debt, with net debt of -$48.52M.